|
OMIM |
Link |
Information gain |
01 |
|
necrotizing encephalopathy, acute, autosomal dominant
|
[NCBI]
|
0.000900049
|
|
|
autoimmune thyroid disease, susceptibility to, 1
|
[NCBI]
|
0.000764597
|
|
|
MCDU
|
[NCBI]
|
0.000724991
|
|
|
MBL2
|
[NCBI]
|
0.000625542
|
|
|
folic acid, transport defect involving
|
[NCBI]
|
0.000625244
|
|
|
neutropenia, chronic familial
|
[NCBI]
|
0.00056504
|
|
|
IGAD1
|
[NCBI]
|
0.000480827
|
|
|
EEC1
|
[NCBI]
|
0.000408031
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
0.000372668
|
|
|
SLE
|
[NCBI]
|
0.000326892
|
|
|
TNF
|
[NCBI]
|
0.000249259
|
|
|
CVID
|
[NCBI]
|
0.000246419
|
|
|
CGD
|
[NCBI]
|
0.000146671
|
|
|
complement factor i deficiency
|
[NCBI]
|
0.000129115
|
|
|
sickle cell anemia
|
[NCBI]
|
0.000114105
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
8.15306e-05
|
|
|
PFC
|
[NCBI]
|
8.04445e-05
|
|
|
RA
|
[NCBI]
|
7.88933e-05
|
|
|
MPO
|
[NCBI]
|
7.39343e-05
|
|
|
CD1A
|
[NCBI]
|
6.70083e-05
|
|
|
CD1E
|
[NCBI]
|
6.70083e-05
|
|
|
microcephaly with chemotactic defect and transient hypogammaglobulinemia
|
[NCBI]
|
6.45122e-05
|
|
|
VEGF
|
[NCBI]
|
6.05226e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
5.59359e-05
|
|
|
whim syndrome
|
[NCBI]
|
5.4534e-05
|
|
|
EFNA5
|
[NCBI]
|
5.32393e-05
|
|
|
UNC93B1
|
[NCBI]
|
5.32393e-05
|
|
|
complement component 8 deficiency, type ii
|
[NCBI]
|
5.32393e-05
|
|
|
ALB
|
[NCBI]
|
5.26571e-05
|
|
|
TLR9
|
[NCBI]
|
5.07698e-05
|
|
|
myeloperoxidase deficiency
|
[NCBI]
|
5.02428e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
[NCBI]
|
5.02428e-05
|
|
|
CCR5
|
[NCBI]
|
5.00133e-05
|
|
|
F3
|
[NCBI]
|
4.88573e-05
|
|
|
GNLY
|
[NCBI]
|
4.80496e-05
|
|
|
CD1C
|
[NCBI]
|
4.80496e-05
|
|
|
TCBA1
|
[NCBI]
|
4.80496e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
4.75175e-05
|
|
|
HHS
|
[NCBI]
|
4.68784e-05
|
|
|
complement component 5 deficiency
|
[NCBI]
|
4.68784e-05
|
|
|
EPO
|
[NCBI]
|
4.68693e-05
|
|
|
LBP
|
[NCBI]
|
4.57279e-05
|
|
|
GS2
|
[NCBI]
|
4.54347e-05
|
|
|
CD1B
|
[NCBI]
|
4.46834e-05
|
|
|
CD1D
|
[NCBI]
|
4.46834e-05
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
4.41144e-05
|
|
|
SGD
|
[NCBI]
|
4.41144e-05
|
|
|
HHS
|
[NCBI]
|
4.28983e-05
|
|
|
EEA1
|
[NCBI]
|
4.21834e-05
|
|
|
kaposi sarcoma
|
[NCBI]
|
4.17715e-05
|
|
|
CDG2C
|
[NCBI]
|
4.0722e-05
|
|
|
SLC35C1
|
[NCBI]
|
4.01935e-05
|
|
|
KCNJ8
|
[NCBI]
|
4.01935e-05
|
|
|
HLA-DPB1
|
[NCBI]
|
4.01935e-05
|
|
|
VIL
|
[NCBI]
|
4.01935e-05
|
|
|
USF2
|
[NCBI]
|
3.85407e-05
|
|
|
IL27RA
|
[NCBI]
|
3.85407e-05
|
|
|
heart block, congenital
|
[NCBI]
|
3.79493e-05
|
|
|
SCN1
|
[NCBI]
|
3.71279e-05
|
|
|
CFD
|
[NCBI]
|
3.71275e-05
|
|
|
EPHB2
|
[NCBI]
|
3.71275e-05
|
|
|
propionic acidemia
|
[NCBI]
|
3.63491e-05
|
|
|
IPEX
|
[NCBI]
|
3.63491e-05
|
|
|
AD
|
[NCBI]
|
3.615e-05
|
|
|
USF1
|
[NCBI]
|
3.58933e-05
|
|
|
HNA
|
[NCBI]
|
3.4231e-05
|
|
|
G6PD
|
[NCBI]
|
3.41292e-05
|
|
|
IL17A
|
[NCBI]
|
3.38142e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
3.35875e-05
|
|
|
TLR4
|
[NCBI]
|
3.31571e-05
|
|
|
AEZ
|
[NCBI]
|
3.2971e-05
|
|
|
CYBA
|
[NCBI]
|
3.2921e-05
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
3.23794e-05
|
|
|
IL12A
|
[NCBI]
|
3.21034e-05
|
|
|
C5
|
[NCBI]
|
3.13497e-05
|
|
|
glycogen storage disease ib
|
[NCBI]
|
3.0737e-05
|
|
|
IRF1
|
[NCBI]
|
3.06507e-05
|
|
|
LAD
|
[NCBI]
|
2.97378e-05
|
|
|
HAMP
|
[NCBI]
|
2.88159e-05
|
|
|
CFB
|
[NCBI]
|
2.88159e-05
|
|
|
NOS2A
|
[NCBI]
|
2.82751e-05
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
2.79281e-05
|
|
|
PTX3
|
[NCBI]
|
2.6816e-05
|
|
|
OMP
|
[NCBI]
|
2.59551e-05
|
|
|
IFNG
|
[NCBI]
|
2.59551e-05
|
|
|
CD40LG
|
[NCBI]
|
2.51665e-05
|
|
|
EGF
|
[NCBI]
|
2.47725e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
2.44393e-05
|
|
|
TFRC
|
[NCBI]
|
2.44393e-05
|
|
|
CTLA4
|
[NCBI]
|
2.40959e-05
|
|
|
SCIDX1
|
[NCBI]
|
2.35927e-05
|
|
|
C3
|
[NCBI]
|
2.22668e-05
|
|
|
ED1
|
[NCBI]
|
2.1857e-05
|
|
|
SLC11A1
|
[NCBI]
|
2.098e-05
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
2.03265e-05
|
|
|
SH2D1A
|
[NCBI]
|
2.02874e-05
|
|
|
TPMT
|
[NCBI]
|
1.92403e-05
|
|
|
FOXP3
|
[NCBI]
|
1.90449e-05
|
|
|
IL2
|
[NCBI]
|
1.85061e-05
|
|
|
CHH
|
[NCBI]
|
1.77336e-05
|
|
|
FOP
|
[NCBI]
|
1.662e-05
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
1.63983e-05
|
|
|
IL10
|
[NCBI]
|
1.63983e-05
|
|
|
CPB2
|
[NCBI]
|
1.61182e-05
|
|
|
PSORS1
|
[NCBI]
|
1.59327e-05
|
|
|
SDS
|
[NCBI]
|
1.45237e-05
|
|
|
AT
|
[NCBI]
|
1.44716e-05
|
|
|
TFPI
|
[NCBI]
|
1.35105e-05
|
|
|
BTK
|
[NCBI]
|
1.28605e-05
|
|
|
PTK2
|
[NCBI]
|
1.13076e-05
|
|
|
CRH
|
[NCBI]
|
1.11483e-05
|
|
|
IL6
|
[NCBI]
|
1.05645e-05
|
|
|
PRL
|
[NCBI]
|
1.05234e-05
|
|
|
CF
|
[NCBI]
|
1.01665e-05
|
|
|
HBA1
|
[NCBI]
|
9.97624e-06
|
|
|
IP
|
[NCBI]
|
9.33956e-06
|
|
|
PTH
|
[NCBI]
|
9.30122e-06
|
|
|
CRC
|
[NCBI]
|
9.12444e-06
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
8.40813e-06
|
|
|
TTR
|
[NCBI]
|
8.22757e-06
|
|
|
GPI
|
[NCBI]
|
7.74982e-06
|
|
|
NGFB
|
[NCBI]
|
7.26625e-06
|
|
|
PCD
|
[NCBI]
|
6.89028e-06
|
|
|
PYY
|
[NCBI]
|
6.83399e-06
|
|
|
HFE
|
[NCBI]
|
6.49663e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
6.28233e-06
|
|
|
STAT3
|
[NCBI]
|
5.97562e-06
|
|
|
CP
|
[NCBI]
|
5.8771e-06
|
|
|
CHS
|
[NCBI]
|
5.16438e-06
|
|
|
APOE
|
[NCBI]
|
4.77354e-06
|
|
|
SLOS
|
[NCBI]
|
4.26634e-06
|
|
|
FA
|
[NCBI]
|
4.23561e-06
|
|
|
HP
|
[NCBI]
|
3.60264e-06
|
|
|
AVP
|
[NCBI]
|
3.4556e-06
|
|
|
GNRH1
|
[NCBI]
|
3.11602e-06
|
|
|
VIP
|
[NCBI]
|
2.76037e-06
|
|
|
PD
|
[NCBI]
|
2.68253e-06
|
|
|
NPY
|
[NCBI]
|
2.35219e-06
|
|
|
HGF
|
[NCBI]
|
2.1739e-06
|
|
|
XDH
|
[NCBI]
|
2.08755e-06
|
|
|
WAS
|
[NCBI]
|
1.71657e-06
|
|
|
CAT
|
[NCBI]
|
1.31104e-06
|
|
|
LPL
|
[NCBI]
|
1.06048e-06
|
|
|
polycystic kidneys
|
[NCBI]
|
5.43192e-07
|
|
|
HBB
|
[NCBI]
|
4.73747e-07
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
4.10138e-07
|
|
|
CJD
|
[NCBI]
|
1.50719e-07
|
|
|
temporal arteritis
|
[NCBI]
|
4.86227e-08
|
|
|
MBP
|
[NCBI]
|
4.19029e-08
|
|
|
TNFSF6
|
[NCBI]
|
2.9314e-08
|
|
|
VDR
|
[NCBI]
|
2.37303e-08
|
|
|
ADA
|
[NCBI]
|
7.28252e-09
|
|
|
RNASE3
|
[NCBI]
|
1.04001e-09
|
|